---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-145767"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:41:52.506638+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organogenesis stockholders approve Series A conversion issuance and director elections at 2025 annual meeting

## Summary
- Stockholders approved issuance of >20% of Class A common stock upon conversion of Series A Preferred at less than Nasdaq minimum price.
- All nine director nominees elected; Garrett Lustig re-elected via Series A written consent with vote tallies of ~72M for.
- Advisory 'say-on-pay' proposal approved with 67.1M votes for, 6.3M against.
- Ratification of RSM US LLP as independent auditor for FY2025 passed with 103.6M votes for, 3.9M against.

## SEC filing metadata
- accession: 0001193125-25-145767
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000119312525145767/0001193125-25-145767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000119312525145767/d887674d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-145767
- JSON: https://secwatch.observer/filing/0001193125-25-145767.json
- Plain text: https://secwatch.observer/filing/0001193125-25-145767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
